Necsa inks deal for tech used in nuclear medicine with Russia’s Rusatom Healthcare
In terms of the deal, two small ‘solution reactors’ will be built in SA as well as a commercial cyclotron for the production of radio-pharmaceuticals
The state-owned South African Nuclear Energy Corporation (Necsa) and the healthcare division of its Russian counterpart, Rosatom, have signed a co-operation agreement for nonpower-related uses of nuclear technology. This paves the way for closer collaboration in the field of nuclear medicine. The agreement, which was signed on the sidelines of the Brics Summit under way in Sandton, will see Necsa partner with Rusatom Healthcare to build two small "solution reactors" in SA, designed for making nuclear medicine products. They also plan to build a commercial cyclotron for the production of radio-pharmaceuticals. "Both parties have a great deal of expertise in this sector and we believe that a combined effort will open up new markets and hasten new technological advancements … Nuclear medicine is rapidly expanding globally and plays a vitally important role in the early detection of cancers and other noncommunicable diseases," Rusatom Healthcare director-general Denis Cherednichenko sai...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.